NovaBay Pharmaceuticals Inc (NBY) — Capital Reinvestment Ratio
NovaBay Pharmaceuticals Inc (NBY) has a Capital Reinvestment Ratio of 0.26x as of September 2017, meaning it reinvests 0% of its operating cash flow ($281.00K) in capital expenditures ($73.00K). Check NovaBay Pharmaceuticals Inc tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NovaBay Pharmaceuticals Inc Capital Reinvestment Ratio (2006–2010)
This chart tracks NovaBay Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see NBY cash flow conversion.
Annual Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc (2006–2010)
Year-by-year Capital Reinvestment Ratio for NovaBay Pharmaceuticals Inc from 2006 to 2010. See NovaBay Pharmaceuticals Inc (NBY) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2010 | 0.10x | $2.03 Million | $203.00K | ▲ +31.2% |
| 2006 | 0.08x | $4.74 Million | $362.00K | — |